can semaglutide cause colon cancer The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and Do GLP-1 Medications Improve Breast

Wegovy is a GLP-1 receptor agonist anti-obesity medication that has several cardiovascular benefits, based on data from the SELECT Trial published last fall in The New England Journal of Medicine

Adequate fiber and fluid intake can help, though finding the right balance can be challenging when also dealing with nausea

The objective of the study is to describe the clinical, pharmacological, and therapeutic profile of semaglutide in the context of obesity management, including mechanism of action, pharmacokinetic characteristics, efficacy, safety considerations, dosing strategies, and future directions

At high doses, niacin can affect liver enzymes and blood sugar levels

Additionally, diabetes-related emotional distress and depression symptom severity have been identified as risk factors for medication non-adherence in T2DM [136, 137]